Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Akimasa Hayashi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7424-8127; OpenAlex author ID A5017068781. Sources: OpenAlex.

Their work

Papers
18 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
50
Papers, trials and grants by year

2019: 1 paper · 2020: 4 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 3 papers · 2026: 6 papers

Papers 18

  1. Molecular landscape of anaplastic transformation in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/path.70136↗
  2. Diagnostic utility of MUC4 expression for distinguishing pancreatic ductal adenocarcinoma from extrahepatic cholangiocarcinoma and its clinicopathological sign… Last author DOI 10.1016/j.humpath.2026.106137↗
  3. Prognostic impact of imaging tumor regression adjacent to major arteries after preoperative chemotherapy in surgical patients with advanced pancreatic cancer. Co-author DOI 10.1016/j.suronc.2026.102574↗
  4. Genomic evolution of pancreatic cancer at single-cell resolution. Co-author DOI 10.1038/s41588-025-02468-9↗
  5. Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-1117↗
  6. POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer Co-author DOI 10.64898/2026.03.15.711961↗
  7. Epigenetic evolution and clinicopathological implications of distinct DNA methylation profiles in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41598-025-13919-y↗
  8. The Evolutionary Forest of Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-23-1541↗
  9. The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions. Co-author DOI 10.1158/2767-9764.crc-24-0167↗
  10. Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreatic ductal adenocarcinoma. First author DOI 10.1038/s41598-024-65900-w↗
  11. A Targetable Secreted Neural Protein Drives Pancreatic Cancer Metastatic Colonization and HIF1α Nuclear Retention. Co-author DOI 10.1158/2159-8290.cd-23-1323↗
  12. Application of high-throughput single-nucleus DNA sequencing in pancreatic cancer. Co-author DOI 10.1038/s41467-023-36344-z↗
  13. The pancreatic cancer genome revisited. Co-author DOI 10.1038/s41575-021-00463-z↗
  14. Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41379-020-0549-5↗
  15. A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s43018-019-0010-1↗
  16. Evolutionary Dynamics of Non-Coding Regions in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1101/2020.09.11.294389↗
  17. The Evolutionary Origins of Recurrent Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-19-1508↗
  18. The Genetic Basis of Transcriptional and Spatial Heterogeneity of Squamous Features in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1101/548354↗

Closest collaborators

The 25 strongest of 50 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christine A. Iacobuzio–Donahue · 15 shared papers, 2019–2026 · strength 2.45
  2. Jungeui Hong · 10 shared papers, 2019–2026 · strength 1.57
  3. Eileen Mary O'Reilly · 9 shared papers, 2020–2026 · strength 1.44
  4. Yoshihiro Sakamoto · 5 shared papers, 2024–2026 · strength 1.23
  5. Junji Shibahara · 5 shared papers, 2024–2026 · strength 1.23
  6. Wungki Park · 5 shared papers, 2025–2026 · strength 1.09
  7. Takahiro Shibayama · 4 shared papers, 2024–2026 · strength 0.94
  8. Alvin P. Makohon-Moore · 7 shared papers, 2019–2025 · strength 0.89
  9. Caitlin A. McIntyre · 5 shared papers, 2020–2026 · strength 0.88
  10. Haochen Zhang · 4 shared papers, 2023–2026 · strength 0.78
  11. Marc A. Attiyeh · 5 shared papers, 2019–2025 · strength 0.52
  12. Naohiro Okano · 2 shared papers, 2024–2026 · strength 0.46
  13. Olca Baştürk · 4 shared papers, 2019–2026 · strength 0.43
  14. Benjamin J. Raphael · 2 shared papers, 2025–2026 · strength 0.43
  15. Hitomi Sakamoto · 4 shared papers, 2019–2025 · strength 0.43
  16. Laura DeLong Wood · 4 shared papers, 2019–2025 · strength 0.43
  17. Keiichiro Kitahama · 2 shared papers, 2024–2025 · strength 0.42
  18. Dana Pe'er · 2 shared papers, 2026 · strength 0.42
  19. Marc Hilmi · 2 shared papers, 2026 · strength 0.42
  20. Marinela Capanu · 2 shared papers, 2025–2026 · strength 0.38
  21. Katelyn Mullen · 2 shared papers, 2023–2025 · strength 0.36
  22. Zachary A. Kohutek · 3 shared papers, 2019–2025 · strength 0.34
  23. Scott W. Lowe · 2 shared papers, 2020–2026 · strength 0.32
  24. Hirokazu Momose · 1 shared paper, 2026 · strength 0.29
  25. Saori Funakoshi · 1 shared paper, 2026 · strength 0.29

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.